After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...